Q3 2024 Earnings Call Transcript November 6, 2024 Tandem Diabetes Care, Inc. beats earnings expectations. Reported EPS is $-0 ...

After multiple rejections, Lexicon Pharmaceuticals is inching toward an FDA decision date next month for its adjunct type 1 ...

We are living in exciting times regarding therapies for people with diabetes. Much of the excitement ... precise regulatory guidance will still be needed for discussion and decision making about ...

Good morning, ladies and gentlemen, and welcome to the Humacyte Third Quarter 2024 Results Conference Call. Currently, all participants are in a listen-only mode. Later, we will conduct a question-and ...

Leigh Vosseller; Chief Financial Officer, Executive Vice President, Treasurer; Tandem Diabetes Care Inc Steve Lichtman; Analyst; Oppenheimer & Co.

Taking steps to prevent and manage diabetes by blood sugar monitoring ... rapidly and can enter advanced stages with little warning. Engaging patients in discussions about risk factors and symptoms ...

The famed self-trained historian Pathisa Nyathi has died aged 73 as a result of complications with diabetes. He has been described by many as a brilliant historian, a living library, an archive of ...

Continue to advance hypoimmune technology in three trials across five indications in type 1 diabetes, B-cell mediated autoimmune diseases, and ...

The CNN pundit Bakari Sellers suggested Sunday that Joe Biden should call on his ex-prosecutor vice president to replace ...

The FDA panel voted against the approval of sotagliflozin for patients with type 1 diabetes and chronic kidney disease.

There's a new player in the running game, and it's not the latest carbon-plated shoe or fancy GPS watch. GLP-1 medications ...

DURHAM, N.C., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at ...